A comparison of dermal toxicity models; assessing suitability for safe(r)-by-design decision-making and for screening nanomaterial hazards

McLean, Polly; Marshall, Jessica; García, Amaia; Beal, David; Katsumiti, Alberto; Carrière, Marie; Boyles, Matthew

Abstract

The objective of Safe-by-Design (SbD) is to support the development of safer products and production processes, and enable safe use throughout a materials' life cycle; an intervention at an early stage of innovation can greatly benefit industry by reducing costs associated with the development of products later found to elicit harmful effects. Early hazard screening can support this process, and is needed for all of the expected nanomaterial exposure routes, including inhalation, ingestion and dermal. In this study, we compare in vitro and ex vivo cell models that represent dermal exposures (including HaCaT cells, primary keratinocytes, and reconstructed human epidermis (RhE)), and when possible consider these in the context of regulatory accepted OECD TG for in vitro dermal irritation. Various benchmark nanomaterials were used to assess markers of cell stress in each cell model. In addition, we evaluated different dosing strategies that have been used when applying the OECD TG for dermal irritation in assessment of nanomaterials, and how inconsistencies in the approach used can have considerable impact of the conclusions made. Although we could not demonstrate alignment of all models used, there was an indication that the simpler in vitro cell model aligned more closely with RhE tissue than ex vivo primary keratinocytes, supporting the use of HaCaT cells for screening of dermal toxicity of nanomaterials and in early-stage SbD decision-making.

Citation

McLean, P., Marshall, J., García, A., Beal, D., Katsumiti, A., Carrière, M., & Boyles, M. (2024). A comparison of dermal toxicity models; assessing suitability for safe(r)-by-design decision-making and for screening nanomaterial hazards. Toxicology in Vitro, 97, Article 105792. https://doi.org/10.1016/j.tiv.2024.105792

• Journal Article Type: Article
• Acceptance Date: Feb 13, 2024
• Online Publication Date: Feb 15, 2024
• Publication Date: 2024-05
• Deposit Date: Feb 19, 2024
• Publicly Available Date: Feb 19, 2024
• Print ISSN: 0887-2333
• Publisher: Elsevier
• Peer Reviewed: Peer Reviewed
• Volume: 97
• Article Number: 105792
• DOI: https://doi.org/10.1016/j.tiv.2024.105792
• Keywords: Nanomaterial, Safe-by-design, Hazard screening, Dermal toxicity, New approach methodologies (NAMs)
• Public URL: http://researchrepository.napier.ac.uk/Output/3511456